Garfield Alastair (CIK 2027261) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-17). Recent activity: Sell RYTM (2,007 shares), Sell RYTM (1,556 shares), Sell RYTM (3,400 shares), Sell RYTM (800 shares), Buy RYTM (4,445 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Scientific Officer | Sell | 2,007 | $233,031 |
| 2026-08-17 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Scientific Officer | Sell | 1,556 | $182,170 |
| 2026-08-17 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Scientific Officer | Sell | 3,400 | $402,167 |
| 2026-08-17 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Scientific Officer | Sell | 800 | $95,335 |
| 2026-07-02 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Scientific Officer | Buy | 4,445 | $0 |
| 2026-07-02 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Scientific Officer | Sell | 2,150 | $237,382 |
| 2026-02-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Scientific Officer | Buy | 6,663 | $0 |
| 2026-02-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Scientific Officer | Sell | 2,026 | $220,814 |
| 2025-07-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Scientific Officer | Buy | 4,445 | $0 |
| 2025-07-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Scientific Officer | Sell | 1,313 | $85,096 |
| 2025-07-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Scientific Officer | Sell | 6 | $388 |
Source: SEC Form 4 filings · as of 2026-08-17